Received Jun 24, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | 2 | — | — |
neurological damage; This is a spontaneous report received from a Consumer or other non HCP. A patient (age and gender not provided) received BNT162b2 (BNT162B2), in 2021 as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (DOSE 1, SINGLE; MANUFACTURER UNKNOWN), administration date: 2021, for COVID-19 immunisation. The following information was reported: NERVOUS SYSTEM DISORDER (non-serious), outcome "unknown", described as "neurological damage". Additional information: It was reported by the reporter on behalf of a patient, who was suffering from symptoms of neurological damage. According to (Privacy), the patient was healthy and began with these symptoms after getting the covid vaccine for 2021 and having been given 2 doses 21 days apart. I asked him for the patient's medical history and information, he refused. The information on the batch/lot number for BNT162b2 will be requested and submitted if and when received.